SecBot SecBot
8-K ·Filed May 8, 2026

EW

Edwards Lifesciences Corp
NEUTRAL
Impact 2/10
Horizonmonths Processed6mo ago SEC0001099800-26-000028
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for future equity issuances under the expanded plan, but no near-term trading catalyst. The filing is routine and does not change the company's financial outlook.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$77.08
T+0 close · May 8, 2026 · via day close
Latest settled
+15.36%
T+60 · $88.92
Vs SPY
+11.24%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 11 $77.08entry
  2. T+1 · 6mo ago +3.07%α +3.21% · $79.45
  3. T+5 · 6mo ago +6.79%α +6.87% · $82.31
  4. T+20 · 5mo ago +13.57%α +13.88% · $87.54
  5. T+60 · 3mo ago +15.36%α +11.24% · $88.92

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Edwards Lifesciences reported the results of its 2026 Annual Meeting, where stockholders approved an amendment to the Long-Term Stock Incentive Compensation Program, increasing the share pool by 7 million shares to 341.5 million. All director nominees were elected, and other proposals including say-on-pay and auditor ratification passed. This is a routine administrative filing with no material financial impact.

Key Facts

  • Stockholders approved Amended and Restated Long-Term Stock Incentive Compensation Program, increasing share pool by 7,000,000 shares to a total of 341,500,000 shares.
  • All nine director nominees were elected with majority votes.
  • Advisory vote on executive compensation passed with 424,961,639 for and 50,924,101 against.
  • Ratification of PricewaterhouseCoopers as independent auditor approved with 446,283,142 for and 56,814,075 against.
  • Vote on the compensation plan passed with 456,675,201 for and 19,210,539 against.

Financial Impact

No immediate financial impact; potential future dilution from increased share authorization is minimal relative to outstanding shares.

dilution

Risk Factors

  • Potential dilution from future equity grants under the expanded share pool.
  • No other material risks identified.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
74% bullish (43 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001099800-26-000028
Document: 0001099800-26-000028-index-headers.html0001099800-26-000028
Document: 0001099800-26-000028-index.html0001099800-26-000028
Document: 0001099800-26-000028.txt0001099800-26-000028

Track record

27 reports on EW

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
  2. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
  3. Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
  4. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
  5. Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
  7. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
  8. Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
  9. Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
  10. Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Wed (10h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026